Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
9.36
Dollar change
-0.79
Percentage change
-7.78
%
IndexRUT P/E- EPS (ttm)-0.35 Insider Own2.53% Shs Outstand298.69M Perf Week-3.80%
Market Cap2.58B Forward P/E64.20 EPS next Y0.15 Insider Trans-0.69% Shs Float291.26M Perf Month-9.74%
Income-104.69M PEG- EPS next Q0.02 Inst Own102.66% Short Float7.15% Perf Quarter-15.37%
Sales493.67M P/S5.22 EPS this Y60.93% Inst Trans-1.93% Short Ratio8.11 Perf Half Y-7.69%
Book/sh0.60 P/B15.63 EPS next Y173.18% ROA-13.50% Short Interest20.83M Perf Year-24.09%
Cash/sh0.91 P/C10.33 EPS next 5Y- ROE-67.09% 52W Range9.02 - 14.57 Perf YTD-34.04%
Dividend Est.- P/FCF- EPS past 5Y22.84% ROI-17.02% 52W High-35.76% Beta0.60
Dividend TTM- Quick Ratio2.42 Sales past 5Y37.81% Gross Margin88.23% 52W Low3.77% ATR (14)0.36
Dividend Ex-Date- Current Ratio3.15 EPS Y/Y TTM41.95% Oper. Margin2.92% RSI (14)33.68 Volatility3.53% 3.11%
Employees517 Debt/Eq2.49 Sales Y/Y TTM32.58% Profit Margin-21.21% Recom1.46 Target Price17.33
Option/ShortYes / Yes LT Debt/Eq2.44 EPS Q/Q69.73% Payout- Rel Volume1.60 Prev Close10.15
Sales Surprise4.88% EPS Surprise-1766.67% Sales Q/Q36.73% EarningsNov 06 BMO Avg Volume2.57M Price9.36
SMA20-4.43% SMA50-11.14% SMA200-12.67% Trades Volume4,099,479 Change-7.78%
Date Action Analyst Rating Change Price Target Change
Dec-13-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $12
Sep-06-24Initiated Jefferies Buy $18
May-30-24Initiated Wells Fargo Overweight $18
May-14-24Upgrade Guggenheim Neutral → Buy $13
Dec-19-23Upgrade Morgan Stanley Equal-Weight → Overweight $15 → $20
Sep-09-22Initiated Morgan Stanley Equal-Weight $14
Apr-13-22Resumed Goldman Neutral $11
Jan-14-22Upgrade SVB Leerink Mkt Perform → Outperform $12 → $16
Nov-15-21Upgrade Stifel Hold → Buy $12 → $16
Sep-30-21Upgrade JP Morgan Neutral → Overweight $16
Dec-13-24 02:10PM
09:50AM
Dec-06-24 11:31AM
Nov-07-24 09:50AM
02:09AM
12:26AM Loading…
12:26AM
Nov-06-24 08:30PM
08:25AM
07:22AM
07:00AM
Nov-04-24 09:55AM
Nov-01-24 07:00AM
Oct-30-24 10:01AM
Oct-28-24 07:00AM
Oct-21-24 09:50AM
12:20PM Loading…
Oct-18-24 12:20PM
09:55AM
09:55AM
06:41AM
Oct-17-24 11:07AM
07:00AM
Oct-09-24 05:35PM
Oct-07-24 05:02PM
Oct-04-24 07:00AM
Sep-24-24 11:50PM
Sep-03-24 07:46AM
07:05AM
07:00AM
Aug-30-24 07:00AM
Aug-21-24 11:24AM
10:31AM Loading…
Aug-09-24 10:31AM
Aug-08-24 09:00PM
08:25AM
07:22AM
07:00AM
Jul-30-24 07:00AM
Jun-26-24 09:47AM
Jun-05-24 07:00AM
Jun-04-24 07:00AM
May-24-24 08:30AM
May-14-24 07:15AM
May-10-24 04:03PM
01:10PM
11:33AM
10:46AM
May-09-24 10:30PM
11:56AM
08:26AM
08:25AM
07:21AM
07:00AM
May-08-24 07:00AM
May-01-24 10:01AM
07:00AM
Mar-29-24 11:30AM
Mar-26-24 09:53AM
Mar-20-24 07:00AM
Mar-13-24 07:07AM
Mar-06-24 11:56PM
Mar-05-24 01:50PM
Mar-01-24 07:00AM
Feb-29-24 11:25AM
11:23AM
Feb-28-24 11:49PM
08:20AM
07:32AM
07:00AM
Feb-15-24 07:00AM
Feb-09-24 03:14PM
Feb-08-24 07:00AM
Feb-01-24 07:00AM
Jan-12-24 11:02PM
09:31AM
Jan-08-24 09:40AM
Jan-07-24 04:00PM
Jan-05-24 07:02PM
Jan-03-24 11:46AM
07:00AM
Dec-30-23 09:01AM
Dec-29-23 09:48AM
07:01AM
Dec-24-23 06:17AM
Dec-21-23 05:01AM
Dec-08-23 11:30AM
Dec-05-23 06:38AM
06:00AM
05:30AM
Nov-15-23 09:48AM
Nov-10-23 10:07AM
Nov-09-23 01:02PM
Nov-08-23 07:13AM
07:00AM
Nov-04-23 05:03AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
07:00AM
Oct-27-23 07:00AM
Oct-08-23 07:00AM
Oct-05-23 07:45PM
03:01AM
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell Bradley LPresident and CEODec 02 '24Option Exercise8.617,50064,575894,154Dec 03 06:12 PM
Campbell Bradley LPresident and CEODec 02 '24Sale10.027,50075,124886,654Dec 03 06:12 PM
BRADLEY CAMPBELLDirectorDec 02 '24Proposed Sale9.987,50074,850Dec 02 04:43 PM
Campbell Bradley LPresident and CEONov 06 '24Option Exercise12.287,90197,024894,555Nov 07 05:49 PM
Campbell Bradley LPresident and CEONov 06 '24Sale12.507,90198,800886,654Nov 07 05:49 PM
BRADLEY CAMPBELLDirectorNov 06 '24Proposed Sale11.747,90192,758Nov 06 05:03 PM
Campbell Bradley LPresident and CEONov 01 '24Option Exercise8.617,50064,575894,154Nov 04 06:23 PM
Campbell Bradley LPresident and CEONov 01 '24Sale11.467,50085,960886,654Nov 04 06:23 PM
BRADLEY CAMPBELLDirectorNov 01 '24Proposed Sale11.427,50085,650Nov 01 04:49 PM
Campbell Bradley LPresident and CEOOct 01 '24Option Exercise8.617,50064,575894,154Oct 04 04:05 PM
Campbell Bradley LPresident and CEOOct 01 '24Sale10.607,50079,492886,654Oct 04 04:05 PM
BRADLEY CAMPBELLDirectorOct 01 '24Proposed Sale10.687,50080,100Oct 01 04:35 PM
Campbell Bradley LPresident and CEOSep 03 '24Option Exercise8.617,50064,575894,154Sep 05 05:01 PM
Campbell Bradley LPresident and CEOSep 03 '24Sale11.717,50087,798886,654Sep 05 05:01 PM
BRADLEY CAMPBELLDirectorSep 03 '24Proposed Sale11.617,50087,075Sep 03 04:19 PM
Campbell Bradley LPresident and CEOAug 01 '24Option Exercise8.617,50064,575894,154Aug 05 08:10 PM
Campbell Bradley LPresident and CEOAug 01 '24Sale10.347,50077,518886,654Aug 05 08:10 PM
BRADLEY CAMPBELLDirectorAug 01 '24Proposed Sale10.317,50077,325Aug 01 04:25 PM
Campbell Bradley LPresident and CEOJul 05 '24Option Exercise8.616,10052,521892,754Jul 09 05:01 PM
Campbell Bradley LPresident and CEOJul 05 '24Sale10.006,10061,029886,654Jul 09 05:01 PM
Campbell Bradley LPresident and CEOJul 01 '24Option Exercise8.611,40012,054888,054Jul 03 04:22 PM
Campbell Bradley LPresident and CEOJul 01 '24Sale10.001,40014,003886,654Jul 03 04:22 PM
Campbell Bradley LPresident and CEOJun 03 '24Option Exercise8.617,50064,575894,154Jun 05 04:35 PM
Campbell Bradley LPresident and CEOJun 03 '24Sale10.007,50075,000886,654Jun 05 04:35 PM
Campbell Bradley LPresident and CEOMay 01 '24Option Exercise8.617,50064,575894,154May 03 05:21 PM
Campbell Bradley LPresident and CEOMay 01 '24Sale10.077,50075,524886,654May 03 05:21 PM
Campbell Bradley LPresident and CEOApr 01 '24Option Exercise8.617,50064,575894,154Apr 03 06:14 PM
Campbell Bradley LPresident and CEOApr 01 '24Sale11.677,50087,496886,654Apr 03 06:14 PM
SBLENDORIO GLENNDirectorMar 07 '24Option Exercise2.8015,00042,00083,596Mar 11 05:36 PM
RAAB MICHAELDirectorMar 05 '24Option Exercise2.8015,00042,00083,596Mar 06 05:22 PM
MCGLYNN MARGARET GDirectorMar 04 '24Option Exercise2.807,50021,00066,789Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 05 '24Option Exercise2.807,50021,00066,789Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 05 '24Sale13.407,500100,50059,289Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 04 '24Sale13.297,50099,67559,289Mar 06 05:21 PM
Campbell Bradley LPresident and CEOMar 01 '24Option Exercise10.5415,833166,904887,052Mar 05 05:14 PM
Campbell Bradley LPresident and CEOMar 01 '24Sale13.1415,833208,017871,219Mar 05 05:14 PM
Crowley John FExecutive ChairmanMar 01 '24Sale13.3529,181389,543573,478Mar 05 05:14 PM
Crowley John FExecutive ChairmanFeb 15 '24Sale13.8131,614436,551697,628Feb 20 05:23 PM
Campbell Bradley LPresident and CEOFeb 15 '24Sale14.004,16758,338871,219Feb 20 05:21 PM
Clark David MichaelChief People OfficerFeb 15 '24Sale14.004,42761,978253,664Feb 20 05:20 PM
Rosenberg EllenChief Legal OfficerFeb 07 '24Option Exercise5.1629,600152,736397,254Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 06 '24Option Exercise5.164002,064368,054Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 07 '24Sale13.0029,600384,818367,654Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 06 '24Sale13.004005,200367,654Feb 08 04:40 PM
Campbell Bradley LPresident and CEOFeb 01 '24Option Exercise10.5415,833166,904891,219Feb 05 07:22 PM
Campbell Bradley LPresident and CEOFeb 01 '24Sale12.5615,833198,858875,386Feb 05 07:22 PM
Crowley John FExecutive ChairmanFeb 01 '24Sale12.6231,614398,918750,838Feb 05 07:22 PM
Crowley John FExecutive ChairmanJan 22 '24Sale12.3655,327683,958782,452Jan 24 05:20 PM
Crowley John FExecutive ChairmanJan 16 '24Sale12.7831,614404,106837,779Jan 18 05:09 PM
Crowley John FExecutive ChairmanJan 10 '24Sale13.6531,614431,452869,393Jan 11 06:33 PM
Clark David MichaelChief People OfficerJan 08 '24Sale14.008,726122,164268,089Jan 09 06:08 PM
Clark David MichaelChief People OfficerJan 09 '24Sale14.001,38419,376266,705Jan 09 06:08 PM
Prout SamanthaChief Accounting OfficerJan 08 '24Sale14.0030,767430,82782,290Jan 09 06:07 PM
Prout SamanthaChief Accounting OfficerJan 09 '24Sale14.001,33718,71880,953Jan 09 06:07 PM
Campbell Bradley LPresident and CEOJan 02 '24Option Exercise10.5415,833166,904956,138Jan 04 06:35 PM
Campbell Bradley LPresident and CEOJan 02 '24Sale14.2315,833225,380947,805Jan 04 06:35 PM
Rosenberg EllenChief Legal OfficerJan 02 '24Option Exercise5.1630,000154,800372,285Jan 04 06:24 PM
Rosenberg EllenChief Legal OfficerJan 02 '24Sale14.2130,000426,219342,285Jan 04 06:24 PM
Castelli JeffChief Development OfficerDec 28 '23Sale14.5217,421252,902340,661Dec 29 05:18 PM
Prout SamanthaChief Accounting OfficerDec 26 '23Sale14.007,659107,228121,912Dec 28 05:09 PM
Rosenberg EllenChief Legal OfficerDec 26 '23Option Exercise5.1630,000154,800372,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 27 '23Option Exercise5.165,00025,800347,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 26 '23Sale14.0030,000420,084342,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 27 '23Sale14.075,00070,327342,285Dec 28 05:08 PM
Castelli JeffChief Development OfficerDec 19 '23Sale13.2517,500231,875359,736Dec 20 04:41 PM
Castelli JeffChief Development OfficerDec 20 '23Sale13.101,65421,667358,082Dec 20 04:41 PM
Crowley John FExecutive ChairmanDec 15 '23Sale12.666,04376,516877,748Dec 19 05:55 PM